Pfizer may also consider retaining the business, one of the largest over the counter products businesses in the world, operating in 90 countries. It markets two of the ten top-selling consumer ...

Pfizer has said it will re-evaluate options for its consumer healthcare business, which sells household name products such as Centrum vitamins and ChapStick lip balm, and plans to make a decision ...

Pfizer’s decision to offload $3.05 billion worth of shares in Haleon is a strategic move driven by shifting priorities in a volatile pharmaceutical market. The transaction, involving 700 million ...

The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from ...

In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...

Haleon was formed in 2022 from a combination of GSK Plc and Pfizer’s consumer-health units. The company makes a wide range of ...

We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other safe stocks to buy ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE)) stands against other undervalued defensive stocks for 2025. The consumer defensive sector covers products that ...

PITTSBURGH, Jan. 17, 2025 (GLOBE NEWSWIRE) -- A California woman has filed a class-action lawsuit claiming pharmaceutical giants Pfizer (PFE ... to helping victims of consumer fraud, sexual ...

(Alliance News) - Pfizer Inc is selling 700 million shares in Haleon PLC, more than halving its remaining stake, according to a statement from JPMorgan Securities on Tuesday. Weybridge-based Haleon is ...